Duke Cancer Center
Duke University Medical Center
Durham, NC
Accepting patients
Larotrectinib
A Pilot and Surgical Study of Larotrectinib for Treatment of Children With Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Tyrosine Kinase (TK) Inhibitor
- Phase 1